Final Glance: Pharmaceuticals companies
AP - Thu Sep 25, 5:02PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies were down at the close of trading:
Final Glance: Medical Devices companies
AP - Thu Sep 25, 5:02PM CDT
NEW YORK (AP) — Shares of some top medical devices companies were down at the close of trading:
Inovio/GeneOne Life Science Collaborate for Ebola Vaccine - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Sep 25, 4:00PM CDT
Inovio Pharmaceuticals, Inc. (INO) is collaborating with GeneOne Life Science for the development of a DNA-based Ebola vaccine.
Valeant (VRX) Sends Letter to Allergan, Provides Q3 Update - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Sep 25, 3:38PM CDT
In a move to strengthen its acquisition offer for Allergan (AGN), Valeant Pharmaceuticals International, Inc. (VRX) announced that it has sent a letter to the former providing an update on its expected third-quarter results.
Why Organovo Holdings Inc Stock Crashed By 40% in 2014
Sean Williams, The Motley Fool - Motley Fool - Thu Sep 25, 1:28PM CDT
It's been an exciting year for investors, with the broad-based S&P 500 up 8% year to date. However, that same sentiment isn't being felt at present by shareholders of Organovo Holdings , a tissue engineering company whose shares have dipped...
Midday Glance: Pharmaceuticals companies
AP - Thu Sep 25, 12:24PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are down at 1 p.m.:
Midday Glance: Medical Devices companies
AP - Thu Sep 25, 12:24PM CDT
NEW YORK (AP) — Shares of some top medical devices companies are down at 1 p.m.:
Early Glance: Pharmaceuticals companies
AP - Thu Sep 25, 10:40AM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are down at 10 a.m.:
Early Glance: Medical Devices companies
AP - Thu Sep 25, 10:40AM CDT
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 10 a.m.:
Pharma Stocks Review - AbbVie, Merck, Johnson and Johnson, GlaxoSmithKline, and Bristol-Myers Squibb
PR Newswire - Thu Sep 25, 8:20AM CDT
On Wednesday, September 24, 2014, the NASDAQ Composite ended at 4,555.22, up 1.03%, the Dow Jones Industrial Average advanced 0.90%, to finish the day at 17,210.06, and the S&P 500 closed at 1,998.30, up 0.78%. The gains were broad based as nine out of ten sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 755.42, up 1.68%, with the index also advancing 7.83% in the previous three months. Investor-Edge has initiated coverage on the following equities: AbbVie Inc. (NYSE: ABBV), Merck and Company Inc. (NYSE: MRK), Johnson and Johnson (NYSE: JNJ), GlaxoSmithKline PLC (NYSE: GSK), and Bristol-Myers Squibb Company (NYSE: BMY). Free research on these five companies can be accessed at:
Acute Coronary Syndrome - Current and Future Players: Amgen, AstraZeneca, Bristol-Myers Squibb, Daiichi Sankyo, Eli Lilly, GSK, Janssen Pharma, Merck, Pfizer & Sanofi
M2 - Thu Sep 25, 4:29AM CDT
Research and Markets (http://www.researchandmarkets.com/research/lx7n7r/pharmapoint) has announced the addition of the "PharmaPoint: Acute Coronary Syndrome - Current and Future Players" report to their offering. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing ACS Market. The report identifies and analyses the key companies shaping and driving the global ACS market. The report provides insight into the competitive ACS landscape, including new companies entering the market. This report is built using data and information sourced from proprietary databases, primary and secondary and in-house analysis by Our team of industry experts. Scope - Investigation of current and future market competition for ACS - Competitor assessment - Coverage of key market players and company profiles including business description, financial overview and SWOT analysis. - Strategic assessment of ACS sector through market impact analysis, future market scenario and company analysis Reasons to buy - Gain a high level view of the trends shaping and driving ACS market - Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition. - Create an effective counter-strategy to gain a competitive advantage against those currently in the market - What's the next big thing in the global ACS market landscape? Identify, understand and capitalize Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Market Outlook 4 Current and Future Players 5 Appendix Companies Mentioned - Amgen - AstraZeneca - Bristol-Myers Squibb - Daiichi Sankyo - Eli Lilly - GlaxoSmithKline - Janssen Pharmaceuticals (Johnson & Johnson) - The Medicines Company - Merck & Co. - Pfizer - Sanofi For more information visit http://www.researchandmarkets.com/research/lx...harmapoint
Allergan and Salix Pharmaceuticals Up on Takeover Rumors - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Sep 24, 3:45PM CDT
Allergan Inc. (AGN) and Salix Pharmaceuticals Ltd. (SLXP) were up after a report from The Wall Street Journal indicated that the former has renewed its attempts to acquire the latter.
Johnson & Johnson Set to Possibly Pullback After Yesterday's Rally of 1.10%
Comtex SmarTrend(R) - Wed Sep 24, 3:42PM CDT
Johnson & Johnson (NYSE:JNJ) traded in a range yesterday that spanned from a low of $107.34 to a high of $108.77. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $108.37 on volume of 5.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Medical Diagnostic Devices Research Digest - H1 2014: Latest News for Medical Devices, In-Vitro Diagnostic Devices & Medical Imaging Devices
M2 - Wed Sep 24, 6:16AM CDT
Research and Markets (http://www.researchandmarkets.com/research/rnbznw/medical) has announced the addition of the "Medical Diagnostic Devices Research Digest - H1 2014" subscription to their offering. The Medical Diagnostic Devices Research Digest is a round-up of all the most important research in the industry each quarter available as an annual subscription, gathered from over 50 sources including associations, market intelligence companies, Journals, company news articles , consultants and industry participants. Updated quarterly, the Digest allows you to: - Quickly update yourself on the latest research findings, gathered and organised for you. - Get our Expert Analysts' perspectives on the latest research. - Link through to the original research to review or purchase. Key Topics Covered: 1 Global Medical Devices Research - Medical Devices M&A Value Falls by Over Half in 2013 Against 2012 - Global Medical Devices Market Showing Only Moderate Growth - Big Fall In Regulatory Approvals of Medical Devices - Top 10 Medical Device Companies 2013 - Cyber-Attacks on Medical Devices Endanger Patients' Lives - US Medical Device Manufacturers Paid $1bn in Excise Tax In 2013 - Strategic Rationale of Medtronic-Covidien Deal - Manufacturing Costs Of Medical Devices Significantly Lower Outside The U.S. - New Trends in Private Healthcare Service Providers in APAC, But Hospitals Remain the Major Providers - China's Healthcare Reform Continues to Drive Its Medical Devices Market 2 In Vitro Diagnostic Devices Research - Global In Vitro Diagnostic (IVD) Devices Market Moderate Growth - Johnson & Johnson Divests Its IVD Business - Becton Dickinson Leads Global Flow Cytometry Market - Clinical Chemistry And Coagulation Tests Dominate North America IVD Market - Cost Of Cholesterol Tests Vary Widely Across The U.S. - Molecular Diagnostics' Rapid Growth In The U.S. IVD Market - U.S. Companion Diagnostics Significant Growth - Hospital-Acquired Infections (HAI) Drive The U.S. Infectious Diseases Testing Market - U.S. IVD Market, Competitive Landscape 2013 - New Entrants Gain Share In The U.S. Blood Testing Market - European Companion Diagnostics' Remarkable Growth - European Law Restricts German IVD Market Growth - French IVD Market Restraints - French Government Strengthens Transparency In Healthcare Sector - Public Healthcare Budget Impacts On Italian IVD Market - Spanish IVD Market Declines Substantially - Nail Test For Bone Quality Launched In The UK - Taxes In Brazil Suppress IVD Market Growth - Brazilian IVD Manufacturers Gain Momentum - Rapid Growth Forecast For Chinese Digital Pathology Market - Public-Private Partnerships Drives Indian IVD Market - Indian IVD Market - Competitive Landscape - Indian Clinical Laboratories Still Use Manual Methods 3 Medical Imaging Devices Research - Diagnostic Ultrasound Market In Developed Economies Depends On Replacement Of Already Installed Systems - Film-Screen Mammography (FSM) Systems Usage Phased Out In Europe - Adoption Of Breast Tomosynthesis System Faster In Europe Than The U.S. - Prices Of CT And MRI Scan Vary Widely Across The U.S. - Medical Imaging Contribution To Washington State's Economy - Mammography Reduces U.S. Mortality Rate - Canadian Initiative Controls Overutilization Of Lumbar MRI Scans - China's Diagnostic X-Ray Imaging Market Sees Rapid Growth Companies Mentioned - Abbott - Abbott Laboratories - Agappe Diagnostics - Arkray - Beckman Coulter Inc. and Becton Dickinson - Bio-Rad and Danaher - CPC Diagnostics - Crescent Diagnostics - DASA Diagnostic Laboratory Group - EMD Millipore - GrupoFleury and Hermes Pardini - Hologic - Hologic - iCyt Sysmex - Johnson and Johnson - LabCorp - Lilac Medicare - Merck - Mindray - Ortho-Clinical Diagnostics - Partec - Qiagen - Quest Diagnostics - Roche Diagnostics - Siemens Healthcare - Sony Technology - Theranosis - Thermo fisher and Alere - Transasia Bio-Medicals - Tulip and Bhat-Biotech For more information visit http://www.researchandmarkets.com/research/rnbznw/medical
New Developments in the Companion Diagnostics Market 2014
M2 - Wed Sep 24, 5:51AM CDT
Research and Markets (http://www.researchandmarkets.com/research/zlp33x/companion) has announced the addition of the "Companion Diagnostics Market" report to their offering. There had been a slow market uptake of companion diagnostics because companion tests lacked FDA approval, which prevented pharmaceutical companies from promoting the diagnostic. But the realization that companion diagnostics can decrease costs by identifying the patient population that will most likely benefit from a therapy and ruling out those therapies not likely to be effective has made companion diagnostics important to the delivery of care. This report, Companion Diagnostics Markets tracks these new developments and focuses on companion diagnostics in medicine in 2013 and 2014. The report provides product analysis for the five broad areas of medical companion diagnostics and market information: Cancer Cardiovascular and Blood Metabolic Infection Neurological Market Size by Disease Area, 2013 and 2018Companion diagnostics have met with considerable challenges in penetrating the market, but are now rising to the forefront of pharmaceutical development and treatment, increasing the probability of clinical success by identifying patients with the presence of biomarkers or disease-specific therapeutic targets that can dramatically improve outcomes. Companion diagnostics and biomarkers provide insight into understanding disease processes and ways that medicines can work to counteract the disease. The majority of competitive participation for companion diagnostics is in the United States and Europe. However, competition is steadily escalating in the United States and Europe, which is encouraging more participation in other areas such as Asia and Latin America. There are numerous companies in the market which include large multiproduct companies such as Roche and Abbott and small niche developers such as 20/20 GeneSystems. Key Topics Covered: ONE: EXECUTIVE SUMMARY TWO: INTRODUCTION TO THE COMPANION DIAGNOSTICS INDUSTRY THREE: INDUSTRY TRENDS FOUR: COMPANION DIAGNOSTIC PRODUCTS FIVE: MARKET SIZE AND GROWTH SIX: COMPANY PROFILES - 20/20 Genesystems, Inc. - Abbott Laboratories - Affymetrix - Asuragen, Inc. - Beckman Coulter, Inc - Becton, Dickinson - Biocartis S.A. - Biodesix, Inc. - Biomerieux Sa - Bioreference Laboratories, Inc - Biotheranostics, Inc. - Cardiodx, Inc - Celera Alameda - Clarient, Inc - Decode Genetics, Inc. - Diagenic Asa - Genomic Health, Inc. - Genoptix Medical Laboratory - Illumina, Inc. - Johnson & Johnson - Life Technologies Corporation (Part Of Thermo Fisher) - Myriad Genetics, Inc. - Nanostring Technologies, Inc. - Opko Health, Inc. - Provista Dx - Qiagen N.V. - Roche - Siemens Healthcare - Singulex, Inc - Thermo Fisher Scientific For more information visit http://www.researchandmarkets.com/research/zlp33x/companion